Nachrichten zur Aktie Dynavax Technologies Corp | A12EV9 | DVAX | US2681582019 Follow DVAX. Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. The biotech had lots of good news. Volume today is 6,389,837 compared to average volume of 8,017,187. DVAX Stock Message Board for Investors. Support: 888-992-3836 | NewsWire | Home | Login / Register. Stock analysis for Dynavax Technologies Corp (DVAX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. By. DVAX stocks went up by 14.46% for the week, with a monthly drop of -8.54% and a quarterly performance of 98.67%, while its annual performance rate touched 215.80%. 557%. View the real-time DVAX price chart on Robinhood and decide if you want to buy or sell commission-free. Holen Sie sich die heißesten Aktien jeden Tag, bevor der Markt öffnet 100% … DVAX is a Stock that could be massively shorted. Dynavax Technologies (DVAX) is a name I have held and followed for years. Over the past 19 days, the trend for DVAX's stories per day has been choppy and unclear. Find market predictions, DVAX financials and market news. Subscribe. Looking further, we note that the PEG ratio for the DVAX stock currently stands at 0, and the most recent price level today is 60.52% off its SMA20 and 92.92% from its 50-day simple moving average. The current RSI for DVAX stock in for the last two-week period is set at 47.42, with the RSI for the last a single of trading hit 40.73, and the three-weeks RSI is set at 51.19 for Dynavax Technologies Corporation [DVAX]. DVAX News Highlights DVAX's 30 day story count now stands at 30. Burgess Justin, the Principal Accounting Officer of Dynavax Technologies Corporation, sale 2,958 shares at $8.88 during a trade that took place back on Mar 01, which means that Burgess Justin is holding 8,175 shares at $26,267 based on the most recent closing price. What this means: Dynavax Technologies (DVAX) gets an Overall Rank of 73, which is an above average rank under InvestorsObserver's stock ranking system. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Dynavax against related stocks people have also bought. The average price from analysts is $18.00. TradingView . Stock analysis for Dynavax Technologies Corp (DVAX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Dynavax against related stocks people have also bought. DVAX's 73 means that it ranks higher than 73% of stocks. Search for: Get Free Real Time News Alerts! S&P. Finally, the long-term debt to capital ratio is 77.60. Dynavax Technologies News: This is the News-site for the company Dynavax Technologies on Markets Insider . Dynavax Technologies News: This is the News-site for the company Dynavax Technologies on Markets Insider . Twitter. 117%. About Dynavax Dynavax is a commercial stage biopharmaceutical company developing and commercializing novel vaccines. Finance; Good News For Dynavax Technologies Corporation (NASDAQ:DVAX): Stock Could Rise Another 105.34%. When we switch over and look at the enterprise to sales, we see a ratio of 10.77, with the company’s debt to enterprise value settled at 0.43. We have 9 different ratings for every stock to help you South Jersey Industries Inc. (SJI): Skating on Thin Ice? DVAX, Dynavax Technologies - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Dynavax Technologies Stock Quote: DVAX Stock News, Quotes, Analysis | Investors.com by Joshua Rodriguez; May 19, 2020 May 19, 2020; Dynavax Technologies Corporation (NASDAQ: DVAX) is rocketing early this morning, trading on gains of more than 40%. Opinions of the stock are interesting as 4 analysts out of 4 who provided ratings for Dynavax Technologies Corporation declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”, The 2021 Backdoor Crypto Portfolio (free). View live DYNAVAX TECHNOLOGIES CORP chart to track its stock's price action. The gains come after an SEC filing was… Read More » Dynavax Technologies (DVAX) Stock Pops On COVID-19 News. Today, the average trading volume of DVAX was 6.18M shares. Rule … Find market predictions, DVAX financials and market news. Shares of Dynavax Technologies (NASDAQ: DVAX) were soaring 18.8% as of 10:50 a.m. EST on Friday. View DVAX's stock ratings, price targets, earnings, commentary and news at Smarter Analyst. Can Vertex Energy Inc. (VTNR) Remain Competitive? Search for: Get Free Real Time News Alerts! Previously, the target price had yet another raise to $14, while Evercore ISI analysts kept a Outperform rating on DVAX stock. A high-level overview of Dynavax Technologies Corporation (DVAX) stock. Total debt to assets is 61.67, with long-term debt to equity ratio resting at 365.63. DVAX stocks went up by 14.46% for the week, with a monthly drop of -8.54% and a quarterly performance of 98.67%, while its annual performance rate touched 215.80%. Several research analysts […] More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing. Insider. The stock options were granted on February 1, 2021 at an exercise price of $10.27 per share, which is equal to the closing price of Dynavax (DVAX) common stock on the date of grant. Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. GKP Gulf … This change was narrower than the S&P 500's daily loss of 1.23%. All 'A' Rated Buy Stocks, Insider Selling: Dynavax Technologies Co. (NASDAQ:DVAX) Insider Sells 2,958 Shares of Stock, Dynavax Technologies: A Surprising COVID-19 Play, Biotech Isn't Seeing Much Merger Activity, but Here's a Stock to Like, Dynavax to Present at the H.C. Wainwright Virtual 2021 Global Life Sciences Conference, Dynavax Technologies Corporation (DVAX) CEO Ryan Spencer on Q4 2020 Results - Earnings Call Transcript, Dynavax EPS beats by $0.10, beats on revenue, Dynavax’s Hepatitis B Vaccine Authorized In Europe; Shares Rise 6%, Dynavax wins European approval for Hep B vaccine, Dynavax Announces European Commission Marketing Authorization for HEPLISAV B®, a 2 Dose Adult Hepatitis B Adjuvanted Vaccine, • 3 Electric Vehicle Supplier Stocks to Consider Adding to Your Portfolio, • Video Game Industry in 2021: The Complete Investors Guide. Why Dynavax Stock Is Skyrocketing Today: 150: The Motley Fool: 01.02. DVAX Stock’s Forward Dividend of 0 and its yield of 0% are making investors’ thoughts stronger that it could fall further before the company announces its earnings for the current quarter. Miguel Garrison - February 16, 2021. For DVAX, its 30 day story count is now at 13. After a stumble in the market that brought DVAX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -22.07% of loss for the given period. The big gain came after the company announced better-than-expected fourth-quarter results after the market close on Thursday. It’s free. The gains come after an SEC filing was… Read More » Dynavax Technologies (DVAX) Stock Pops On COVID-19 News. H.C. Wainwright, on the other hand, stated in their research note that they expect to see DVAX reach a price target of $14, previously predicting the price at $12. They are trying to find them, count their potential and bring them to their clients. I have watched it go through a long run to get its best of breed hepatitis B vaccine approved after several attempts (due mainly to FDA intransigence) and into early day of commercialization. Pinterest. Insider. Get the latest Dynavax Technologies Corporation (DVAX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Facebook. dvax stock price: dvax stock price today: dvax stock forecast: dvax stock after hours: dvax stock news: dvax stock today: dvax stock quote: dvax stock yahoo: 12 3 4 5. The stock price of Dynavax Technologies Corporation (NASDAQ: DVAX) – a biopharmaceutical company focused on developing and commercializing novel vaccines – increased by over 9% pre-market as of 8:13 AM ET. The simple moving average for the period of the last 20 days is 5.95% for DVAX … © Copyright - Newspaper WordPress Theme by TagDiv, Get The Best Stocks To Trade Every Day!...100% Free. Current profitability levels for the company are sitting at: The net margin for Dynavax Technologies Corporation stands at -161.63. above. Dynavax Technologies (NASDAQ:DVAX) Intraday Stock Chart Thursday 11 March 2021 Dynavax (DVAX): Q4 GAAP EPS of -$0.14 beats by $0.10.Revenue of $19.55M (+85.0% Y/Y) beats by $6.49M.First quarter 2021 CpG 1018 revenue anticipated to be between $40 million and $60 million.Press Release... Shares of Dynavax Technologies Corp. rose about 6% on Feb. 19 after the biopharmaceutical company announced that its hepatitis B vaccine, Heplisav B has received marketing authorization from the European Commission. Return. During the last 5 trading sessions, DVAX rose by +14.46%, which changed the moving average for the period of 200-days by +86.08% in comparison to the 20-day moving average, which settled at $9.14. Join now to get the NewsHeater.com pre-market morning brief 100% free. Get Best Morning Financial Newsletter... 100% Free. Dynavax Technologies (DVAX) Stock Pops On COVID-19 News. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company. Dynavax Technologies (DVAX) Stock Pops On COVID-19 News. DVAX | Complete Dynavax Technologies Corp. stock news by MarketWatch. The company’s stock price has collected 14.46% of gains in the last five trading sessions. Dynavax Technologies Corporation (NASDAQ:DVAX) went up by 3.25% from its latest closing price compared to the recent 1-year high of $12.44. The approval is based on positive risk-benefit for the vaccine backed by results from three Phase 3 trials. DVAX currently public float of 109.38M and currently shorts hold a 18.61% ratio of that float. Today we are talking about DVAX Stock, Dynavax Technologies is a company that works with novelty vaccines. 6:00a Boeing stock falls 3.6% premarket after United removes 777s from service in wake of engine explosion 6:00a Conquer your fear of public speaking even on … Dynavax Technologies Co. (NASDAQ:DVAX) insider Justin Burgess sold 2,958 shares of the company’s stock in a transaction on Monday, March 1st. Press Release reported on 03/01/21 that Dynavax to Present at the H.C. Wainwright Virtual 2021 Global Life Sciences Conference, Plus, the 36-month beta value for DVAX is at 1.24. The company posted fourth... Bret Jensen on Seeking Alpha | March 1, 2021, The biotech sector isn't seeing much merger-and-acquisition activity or insider stock purchases, but Dynavax Technologies (DVAX) is one stock to like as it has inked a supply deal related to a Covid-19 vaccine that could greatly increase its revenue stream, writes Bret Jensen….XBI. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. View DVAX's stock ratings, price targets, earnings, commentary and news at Smarter Analyst. Get the hottest stocks to trade every day before the market opens 100% free. View the real-time DVAX price chart on Robinhood and decide if you want to buy or sell commission-free. Equity return is now at value -151.90, with -23.20 for asset returns. by Joshua Rodriguez; May 19, 2020 May 19, 2020; Dynavax Technologies Corporation (NASDAQ: DVAX) is rocketing early this morning, trading on gains of more than 40%. Get Dynavax Technologies Corp (DVAX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. The gains come after an SEC filing was made public, suggesting that the company’s COVID-19 vaccine will be headed into human trials. DVAX: Get the latest Dynavax Technologies stock price and detailed information including DVAX news, historical charts and realtime prices. DVAX, Dynavax Technologies - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Dynavax Technologies Stock Quote: DVAX Stock News, Quotes, Analysis | Investors.com Next 151 results. Click here to get the full story… along with our long list of backdoor Bitcoin strategies. We do not sell or share your information with anyone. by Joshua Rodriguez; May 19, 2020 May 19, 2020; Dynavax Technologies Corporation (NASDAQ: DVAX) is rocketing early this morning, trading on gains of more than 40%. Der Preis der Dynavax Technologies Corporation (NASDAQ: DVAX) schloss am Montag, März 59 , Springen 3. Dynavax Technologies (DVAX) Stock Pops On COVID-19 News. appreciate its future potential. The most mentioned tickers in articles about DVAX are. The […]. Get the latest Dynavax Technologies Corporation (DVAX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Volatility was left at 9.13%, however, over the last 30 days, the volatility rate increased by 8.56%, as shares sank -1.27% for the moving average over the last 20 days. The stock traded as high as $9.28 and last traded at $9.14. Finally, Some Good News for Dynavax Technologies This biotech has a vaccine for treating hepatitis B and is now tackling COVID-19. Kailas Salunkhe on TipRanks | February 21, 2021. The stock was sold at an average price of $8.88, for a total transaction of $26,267.04. But it's still valued at less than $1 billion. Evercore ISI gave a rating of “Outperform” to DVAX, setting the target price at $14 in the report published on June 15th of the previous year. Sign Up to See To see all exchange delays and terms of use, please see disclaimer. März 2021 von Valentin Neumann. The biotech had lots of good news. View real-time stock prices and stock quotes for a full financial overview. Stock Fundamentals for DVAX. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! by Joshua Rodriguez; May 19, 2020 May 19, 2020; Dynavax Technologies Corporation (NASDAQ: DVAX) is rocketing early this morning, trading on gains of more than 40%. DVAX Stock Analysis Overview What this means: Dynavax Technologies (DVAX) gets an Overall Rank of 73, which is an above average rank under InvestorsObserver's stock ranking system. It has oscillated between 1 and 4. TradingView. You have entered an incorrect email address! View the latest Dynavax Technologies Corp. (DVAX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Dynavax Technologies Corporation, which has a market valuation of $1.05 Billion, is expected to release its quarterly earnings report on February 25, 2021. Trending Now. View detailed financial information, real-time news, videos, quotes and analysis on Dynavax Technologies Corporation (NASDAQ:DVAX). After this action, Burgess Justin now owns 7,010 shares of Dynavax Technologies Corporation, valued at $10,275 using the latest closing price. 0. Markets Insider. Boards. Equity multiplier, or assets relative to shareholders' equity, comes in at 6.54 for Dynavax Technologies Corp; that's greater than it is for 82.46% of US stocks. The total capital return value is set at -29.83, while invested capital returns managed to touch -30.22. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.75. View live DYNAVAX TECHNOLOGIES CORP chart to track its stock's price action. See Dynavax Technologies Corp. Stock Price, News and Company Updates. View the latest Dynavax Technologies Corp. (DVAX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that the European Commission (EC) has granted Marketing Authorization for HEPLISAV B (Hepatitis B Vaccine (Recombinant), Adjuvanted) for the active immunization against hepatitis B virus infection (HBV) caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. Looking for insights on Dynavax (NCM:DVAX) stock? The gains come after an SEC filing was made public, suggesting that the company’s COVID-19 vaccine will be headed into human trials. EMERYVILLE, Calif. Many brokerage firms have already submitted their reports for DVAX stocks, with H.C. Wainwright repeating the rating for DVAX by listing it as a “Buy.” The predicted price for DVAX in the upcoming period, according to H.C. Wainwright is $12 based on the research report published on August 07th of the previous year 2020. Why Dynavax Stock Is Crushing It Today. DVAX's rank also includes a fundamental score of 88. 121. The new note on the price target was released on August 03, 2020, representing the official price target for Dynavax Technologies Corporation stock. Dynavax Technologies Corporation DVAX was a big mover last session, as the company saw its shares rise nearly 7% on the day. The rating they have provided for DVAX stocks is “Buy” according to the report published on August 03rd, 2020. 8.18-0.29 (-3.42%) Upgrade to Real-Time Afterhours ... DVAX) Intraday Stock Chart Friday 5 March 2021 Your Recent History LSE. Save my name, email, and website in this browser for the next time I comment. The stock options were granted on February 1, 2021 at an exercise price of $10.27 per share, which is equal to the closing price of Dynavax (DVAX) common stock on the date of grant. Just enter your email address below. NewsHeater is specialized on the investments in tech sphere. May 19, 2020 10:39AM EDT (RTTNews) - Shares of the small-cap biotech Dynavax Technologies Corp. (DVAX) surged over 40% on Tuesday morning after the company said it … The gain came after the company announced that its hepatitis B virus (HBV) vaccine Heplisav-B received marketing authorization from the European Commission (EC). Just click the link Here’s what’s going … Following the sale, the insider now directly owns 1,221 shares of the company’s stock, valued at $10,842.48. In the latest trading session, Dynavax Technologies (DVAX) closed at $10.12, marking a -0.3% move from the previous day. Ticker Trading Ideas Educational Ideas Scripts People. Dynavax Technologies Corp. Stock Price, News and Company Updates. Its specialists are interested in stocks that have been undervalued by different reasons. 9. This is why it happened. 34% über dem vorherigen Schlusskurs. Find the latest Dynavax Technologies Corporatio (DVAX) stock quote, history, news and other vital information to help you with your stock trading and investing. The stock price of Dynavax Technologies Corporation (NASDAQ: DVAX) increased by over 9% pre-market.